UConn Health
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, UConn Health sits in the top decile of US sponsors by registered trial count (#168 of 15,742 sponsors by registered trial count).
UConn Health: 178 sponsored US clinical trials, 19 recruiting.
UConn Health sponsors 178 registered US clinical trials on ClinicalTrials.gov, 19 of them currently recruiting, and 132 completed. 25 of these trials are in Phase 3-4 (later-stage) and 23 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alcoholism, with 5 trials.
Top-decile sponsor footprint
UConn Health ranks in the top decile of sponsors by registered trial count (#168 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
132 of 151 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
178 total, page 2 of 4
Knee Injection RCT
NCT03694821
Electronic Cigarette Use During Pregnancy
NCT03480373
Reducing Traffic Pollution Exposure Improves Blood Pressure
NCT04029129
Teacher Anxiety Program for Elementary Students
NCT03899948
Novel PAradigm to Improve Inflammatory Burden in ESRD (rePAIR): A Pilot and Feasibility Randomized Controlled Trial
NCT03241511
A Psychotherapy Development Study for Internet Gaming
NCT03220581
Husky Reads Effectiveness in Increasing Produce Preference and Food Group Identification in Preschool Children
NCT03338257
3D Team Care for Cognitively Vulnerable Older Adults
NCT02945085
Study of Oncoimmunome for the Treatment of Stage III/IV Ovarian Carcinoma
NCT02933073
Individualized Assessment and Treatment for Alcoholism II
NCT03233802
Reducing Internet Gaming
NCT02726880
Effect of Pradaxa vs Warfarin on Bone Mass and Bone Turnover Markers
NCT02791555
Interventions for Unemployed Hazardous Drinkers
NCT02559609
Integrated Treatment for Posttraumatic Stress Disorder and Substance Abuse in Young Adults
NCT02667119
Manipulating Tobacco Constituents in Male Menthol Smokers
NCT02592772
Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty
NCT02664909
Diabetes Risk Reduction Through Eat, Walk, Sleep and Medication Therapy Management for Depressed Cambodians
NCT02502929
Contingency Management to Reduce Alcohol Use in a Soup Kitchen Sample
NCT02499913
Alcohol and ART Adherence in India
NCT03746457
Good Oral Health - A Bi-level Intervention to Improve Older Adult Oral Health
NCT02419144
Translation of COPE for Publicly-Funded Home Care Clients and Their Families
NCT02365051
Enhancement of Corticosteroid Efficacy in COPD
NCT02340520
Extending Long-term Outcomes Through an Adaptive Aftercare Intervention
NCT02143063
Manipulating Tobacco Constituents in Female Menthol Smokers
NCT02048852
Biomarkers of Orthodontic Tooth Movement With Fixed Appliances and Vibration Appliance Therapy
NCT02119455
Ultrasound and Near Infrared Imaging for Breast Cancer Diagnosis and Neoadjuvant Chemotherapy Monitoring
NCT02092636
Photoacoustic Imaging of the Ovary
NCT02110277
Contingency Management for Alcohol Use Disorders
NCT02135237
Study of Freeze-dried Black Raspberry in Maintenance of Ulcerative Colitis
NCT02267694
CM Treatment for Alcohol Dependence Using New Technology
NCT02143037
Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS
NCT01815138
Marijuana Treatment Project 4
NCT02030665
A Pilot Study Examining a Reinforcement Approach to Improve Diabetes Management
NCT01829555
Omega 3 FA Supplements as Augmentation in the Treatment of Depression
NCT01803711
Dutasteride Treatment for the Reduction of Heavy Drinking in Men
NCT01758523
Antiretroviral Therapy Adherence and Secondary Prevention of Human Immunodeficiency Virus
NCT01760759
Effects of Electronic Cigarettes on Nicotine Concentrations
NCT01775787
Contingency Management for Smoking Cessation in the Homeless
NCT01736982
Impact of Bracket Design and Oral Hygiene Maintenance on Halitosis in the Orthodontic Patient
NCT01948349
Experimental Peri-implant Mucositis in Humans
NCT01941797
Nicotine Replacement for Smoking Cessation During Pregnancy
NCT01656733
School-based Treatment of Anxiety Research Study (STARS)
NCT01761396
Manual Unloading of the Lumbar Spine: Can it Predict Responders to Mechanical Traction?
NCT02026076
Mediterranean Diet for Post-menopausal Women: Effects on Bone Turnover
NCT01653275
Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation
NCT01606709
Interactive Voice Response Technology to Mobilize Contingency Management for Smoking Cessation
NCT01484717
Intensive Versus Standard Blood Pressure Lowering to Prevent Functional Decline in Older People
NCT01650402
Comparison of Oral Hygiene & Root Resorption During Orthodontic Treatment
NCT02745626
Contingency Management for Persons With Severe Mental Illness
NCT01478815
Efficiency of Piezotome-Corticision Assisted Orthodontics
NCT02026258
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 8 |
| Phase 2 | 15 |
| Phase 3 | 5 |
| Phase 4 | 20 |
Therapeutic Areas
What is open in the UConn Health pipeline
19 recruiting of 178 indexed (11% open); 132 completed (74%).
Phase mix: 25 late (III/IV) vs 23 early (I/II) (balanced across stages).
Top condition: Alcoholism (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
UConn Health: open-pipeline peers nationwide
Peers matched on 178 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
UConn Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 178 trials (± recruiting share)
- Baylor Research Institute · 180 trials · 17% recruiting
- Abbott · 181 trials · 0% recruiting
- Albert Einstein College of Medicine · 175 trials · 11% recruiting
- ViiV Healthcare · 182 trials · 4% recruiting
Sponsors near 11% open enrollment (± trial volume)
- Hartford Hospital · 11% recruiting · 75 trials
- Tufts Medical Center · 11% recruiting · 169 trials
- CAMC Health System · 11% recruiting · 28 trials
- Carnegie Mellon University · 11% recruiting · 37 trials
Related
What to do with this UConn Health page
178 registered trials is a research-attention snapshot, not an endorsement of UConn Health or any single study.
- 19 of UConn Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alcoholism is the condition UConn Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alcoholism trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
UConn Health pipeline card: 178 registered trials from official public datasets.Report a data error.